Published ahead of print on January 30, 2004, doi:10.1165/rcmb.2003-0223OC
© 2004 American Thoracic Society DOI: 10.1165/rcmb.2003-0223OC Protease-Activated Receptor-2Mediated Inhibition for Ca2+ Response to Lipopolysaccharide in Guinea Pig Tracheal Epithelial CellsDepartment of Pharmacology and Department of Internal Medicine 1, Kansai Medical University, Osaka, Japan Address correspondence to: Chiyoko Inagaki, M.D., Department of Pharmacology, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan. E-mail: inagaki{at}takii.kmu.ac.jp
The protease-activated receptor-2 (PAR-2) has been implicated in airway inflammation. Here, we examined the interaction between PAR-2 and lipopolysaccharide (LPS), a major proinflammatory factor, using cultured guinea pig tracheal epithelial cells. In fura2-loaded cells, LPS (1 µg/ml) transiently increased intracellular Ca2+ concentrations ([Ca2+]i), this effect being abolished by a Ca2+ channel blocker, verapamil, and Ca2+ removal. Prestimulation of PAR-2 with trypsin (0.11 U/ml) or an agonist peptide (SLIGRL-NH2, 1 µM) for 60 min inhibited the LPS-induced [Ca2+]i increase. Such an inhibitory effect of trypsin was abolished by inhibitors of protein kinase C (PKC), chelerythrine and staurosporine. A PKC activator, phorbol 12,13-dibutylate, also reduced the LPS response. Trypsin also inhibited a transient increase in [Ca2+]i caused by a Ca2+ channel opener, Bay K 8644. When the trypsin-pretreated cells were incubated in normal buffer for 1060 min before LPS exposure, the effect of trypsin on the Ca2+ response to LPS diminished in a time-dependent manner. Such a recovery was slowed by incubation with a protein phosphatase inhibitor, okadaic acid. Further, trypsin induced sustained activations of PKC
Abbreviations: 1,4-Dihydro-2, 6-dimethyl-5-nitro-4-[2'-(trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester, (±)-Bay K 8644 fetal calf serum, FCS intracellular Ca2+ concentration, [Ca2+]i Joklik's modified Eagle's medium, JMEM lipopolysaccharide, LPS protease-activated receptor, PAR phorbol 12, 13-dibutylate, PDBu cAMP-dependent protein kinase, PKA protein kinase C, PKC cGMP-dependent protein kinase, PKG soybean trypsin inhibitor, SBTI This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||